Given the potential neuroprotective effects of mGluR1 such as inducing AMPAR endocytosis and reducing NMDAR activity noted earlier in this discussion, its reduction in AD could potentially exacerbate glutamatergic excitotoxicity. The gene discussed is GRM1; the disease is Alzheimer disease.